|Articles|October 9, 2018

Los Angeles Health Officials Investigate Typhus Outbreak

Los Angeles County Department of Public Health is investigating an influx of cases of flea-borne typhus in downtown Los Angeles.

Updated: 10/19/2018 at 12:34 PM EST

Los Angeles County Department of Public Health (Public Health) is investigating an outbreak of flea-borne typhus cases in downtown Los Angeles.

In an email, the Office of Communications and Public Affairs told Contagion® that there have been 11 cases associated with this outbreak and 64 total cases in 2018.

Typhus is endemic to LA County and on average about 60 cases are reported each year. This situation is unique because of the high number of cases reported in a short amount of time.

“Although typhus normally occurs throughout LA County, we are observing several cases in the downtown Los Angeles area,” said Muntu Davis, MD, MPH, Los Angeles County Health Officer in a recent statement. “We encourage pet owners to practice safe flea control and encourage all cities in the county to ensure maintenance of their trash clean-up and rodent control activities.”

Rickesttsia typhi and R felis bacteria are found in infected fleas and their feces, which can cause typhus. The fleas can in turn come in contact with animals and pets that can pass the disease onto humans, despite the fact that animals do not get sick from typhus.

In addition to outdoor pets, fleas can come from wild animals including feral cats, rats and opossums, making areas with garbage accumulation sites that could increase the risk of exposure. While animals can pass the disease to humans, typhus is not spread person-to-person.

Health officials from Public Health are gathering additional information to pinpoint the exact locations of the cases in downtown LA. All 9 cases associated with the outbreak have been reported in individuals who have a history of living or working in the downtown LA area. Details have not been revealed about the ill, but officials indicate that some, not all, of the cases have been reported in homeless people.

According to the US Centers for Disease Control and Prevention (CDC), symptoms can begin within 2 weeks of contact and include of flea-borne typhus include fever and chills, body aches and muscle pain, loss of appetite, nausea, vomiting, stomach pain, cough, and rash.

Most people will recover without treatment, but severe cases can occur, which can result in organ damage including liver, kidneys, heart, lungs and brain if not treated.

There is no vaccine to prevent typhus, but it is effectively treated with doxycycline, which is most effective when it is given soon after the onset of symptoms.

In order to prevent contact and infection, Public Health recommends that individuals avoid contact with rats, opossums, and feral cats. In the event of exposure to fleas during outdoor activities, the CDC recommends the use of Environmental Protection Agency-registered insect repellent.

Additionally, pet owners should protect outdoor pets with veterinarian-approved animal flea control products in order to prevent any contact with infected fleas and reduce the chance of fleas entering living spaces.

This is an ongoing investigation and the Los Angeles Department of Health will continue to provide updates as they become available.

For the most recent case counts associated with the downtown Los Angeles typhus outbreak, check out the Outbreak Monitor.


Related to this article

Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
FAQ: Shamonda Virus
As France confirms the first documented human Shamonda virus infection, a fatal encephalitis in a stem cell transplant recipient, this FAQ explains what the virus is, where it has spread, how the case was diagnosed, how the patient was likely infected and what clinicians should watch for.